Telephone 0808 808 0123
Textphone 0808 808 9000
informationline@rnid.org.uk
The potential markets for new therapeutics aimed at either protecting or restoring hearing, or alleviating tinnitus are vast. There are significant opportunities for companies with expertise in neuroprotection, regenerative biology, gene therapy or implantable medical devices.
BSL clip large: Biomedical market opportunities (2.32MB)
BSL clip small: Biomedical market opportunities (758KB)
Auditory research is taking place in academic institutions all over the world, much of it designed to increase our understanding of diseases and conditions that affect hearing function. More applied research is now needed to turn this knowledge into treatments, so we are actively encouraging and assisting the private sector to get involved in this area.
We do this by:
This year we are developing major new funding initiatives. These will differ from our other grant schemes as they are intended to support work with commercial potential; this potential must be demonstrated in the application. The funding source for these initiatives will be via industry partners, who in return will receive intellectual property, licensing options, shares etc, as negotiated. Find out more about our funding initiatives.
For more information on any of the above contact us at:
RNID, Biomedical Research, 19-23 Featherstone Street, London EC1Y 8SL
Telephone: 020 7294 3742
Textphone: 020 7296 80001 (ext 3742)
Fax: 020 7296 8069
Email: research@rnid.org.uk